In light of Chris Evert’s ovarian cancer diagnosis, OCRA’s Chief Program Officer, Sarah DeFeo, spoke with Fortune Magazine about why knowing risk and taking preventative action can save lives, and about OCRA’s free genetic testing kit program for those at increased risk. Read the article, “With ovarian cancer, there’s no such thing as early detection. Here’s what to learn from tennis great… Source ..read more

Ovarian Cancer Research Alliance is proud to announce that Debra Birnbaum has joined its Board of Directors. Birnbaum is an accomplished multi-platform content creator and media strategist with over 20 years of experience covering news and entertainment, and the current global head of awards for Amazon MGM Studios. Birnbaum’s own connection to ovarian cancer adds a deeply personal dimension… Source ..read more

June is Uterine Cancer Awareness Month and OCRA is dedicated to fighting on behalf of not only the ovarian cancer community but the entire gynecologic cancer community. Uterine cancer is the most common gynecologic cancer in high-income countries, and around 90% of uterine cancers are endometrial cancer types — one of the few cancers experiencing an increase in mortality. At OCRA’s 2024… Source ..read more

The potential to help even one person serves as a powerful motivator for ovarian cancer survivor Marlynn Olivarez and gym owner Krista Iglesias Thomas, two OCRA Heroes who are wholeheartedly devoted to raising funds for ovarian cancer research and bringing more awareness to the disease. “If one life is saved, it’s totally worth it,” said Marlynn, who is preparing for her ninth Ovarian Cycle… Source ..read more

OCRA’s 2024 Early Career Investigator Grants are awarded to 8 outstanding young researchers with a strong commitment to ending ovarian and related gynecologic cancers. These grants fund innovative projects, and support the next generation of scientists dedicated to curing ovarian cancer. “By supporting these early career investigators, we’re fostering innovative approaches and fresh… Source ..read more

Major media outlets including Los Angeles Times, The Hollywood Reporter, Yahoo! Life, and more, have covered the news of Amazon MGM Studios’ Debra Birnbaum joining the Ovarian Cancer Research Alliance (OCRA) Board of Directors. Her appointment has garnered significant attention, highlighting her extensive background in media and her personal connection to ovarian cancer… Source ..read more

New York, NY – June 10, 2024 – Ovarian Cancer Research Alliance (OCRA), the world’s largest organization dedicated to advancing research into ovarian and related gynecologic cancers and supporting patients, is proud to announce that Debra Birnbaum has joined its Board of Directors. Birnbaum is an accomplished multi-platform content creator and media strategist with over 20 years of experience… Source ..read more

Ovarian Cancer Research Alliance’s healthcare education program was featured by News 12 Brooklyn for teaching SUNY Downstate Medical School students things they won’t learn in a textbook. “The textbook can only do so much. It can tell you statistics, it can tell you what some people might feel,” said Mina Boutros, a medical student attending the program. “But every patient is different… Source ..read more

OCRA’s Health Equity Research Grants for 2024 are dedicated to advancing equity in care of ovarian and related gynecologic cancers, addressing deep disparities in early diagnosis, access to care, and patient outcomes. “In a year of remarkable new research being undertaken by OCRA-funded scientists, our expanded focus on health equity is more critical than ever,” says Audra Moran… Source ..read more

Uterine (or endometrial) cancer is the most common type of gynecologic cancer, with more than 860,000 women living with the disease in the U.S. As Ovarian Cancer Research Alliance funds research that aims to cure ovarian and related gynecologic cancers, we are here for those impacted by uterine/endometrial cancer. OCRA’s support programs are open to people impacted by all gynecologic… Source ..read more